100392-00-5 Usage
Molecular Structure
2-(3-ethoxy-4-hydroxy-phenyl)-thiazolidine-4-carboxylic acid is a chemical compound that contains a thiazolidine ring with a carboxylic acid and hydroxy-phenyl group attached to it.
Classification
It belongs to the thiazolidine-4-carboxylic acid class of compounds.
Biological Activity
The ethoxy and hydroxy groups present in the compound suggest potential interactions with biological molecules, making it a potential candidate for drug development.
Pharmaceutical Applications
The compound may have anti-inflammatory, antioxidant, or other pharmaceutical properties due to its structural features.
Further Research
Further research is needed to explore its potential pharmacological activities and therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 100392-00-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,3,9 and 2 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 100392-00:
(8*1)+(7*0)+(6*0)+(5*3)+(4*9)+(3*2)+(2*0)+(1*0)=65
65 % 10 = 5
So 100392-00-5 is a valid CAS Registry Number.
100392-00-5Relevant articles and documents
NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR
-
Paragraph 0135-0137; 0143, (2014/02/16)
Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.